#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxoid liposarcoma Cerebral arteriovenous malformation haemorrhagic Retinopathy of prematurity Von Willebrand's disease Ischaemic stroke Chorioretinitis Anaplastic thyroid cancer Osteochondrodysplasia Oesophageal atresia Familial haemophagocytic lymphohistiocytosis Dent's disease Pleomorphic liposarcoma Alexander disease Leukocyte adhesion deficiency Wolfram syndrome More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Trials in Disease Idiopathic inflammatory myopathy – Life with Disease Angelman’s syndrome – Basic Information Inclusion body myositis Encephalitis autoimmune – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease Basal cell naevus syndrome – Life with Disease Usher’s syndrome – Life with Disease Angiosarcoma recurrent – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cariprazine Modafinil Imatinib Piperacillin Monohydrate Metoclopramide Hydrochloride Glatiramer Acetate Recombinant Interferon Beta-1B Pamapimod Tianeptine Sodium H2-Receptor Antagonist Tominersen Lidocaine Dextrose Bp Axitinib Alendronate Sodium Monohydrate Vosoritide Resiniferatoxin Doxylamine Hydrogen Succinate Antipsychotics Migalastat More therapies…

    Learn about Your Condition

    Rheumatoid arthritis Congenital ureteric anomaly Malignant melanoma Myopia Breast cancer stage III Procedural pain Hepatobiliary cancer Sarcoma Gastrointestinal melanoma Immunodeficiency Endometrial cancer stage I Cardiovascular disorder Thyroid cancer Hyperglycaemia Gastric cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Testing the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Brain stem glioma
    Investigated Drugs:
    • ARI0008
    Spain

  • Study of regorafenib as maintenance treatment after first-line therapy in patients with bone sarcomas without remaining disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Bone sarcoma
    Investigated Drugs:
    • Regorafenib
    France

  • Testing acetylsalicylic acid and ketorolac to reduce complications after cancer surgery in patients with high inflammation levels

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammation
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Acetylsalicylic Acid
    Italy

  • A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Teprotumumab
    France Germany Italy Poland Spain

  • A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Myotonic dystrophy
    Investigated Drugs:
    • ADS-019
    Belgium Germany Italy Spain

  • Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Enoxaparin Sodium
    • Sodium Chloride
    France
Previous Page
1 … 744 745 746 747 748 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!